通过导管修复中膜,以治疗退行性中膜反
Raj R Makkar1, Joanna Chikwe1, Tarun Chakravarty1
1Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.
JAMA
|May 23, 2023
概括
通过导管修复 mitra 的退行性回 (MR) 是安全和有效的,成功率为88. 9%. 温和的残留MR和较低的部梯度显示出最佳结果,包括较低的死亡率.
科学领域:
- 心血管医学
- 干预心脏病学
- 医疗器械
背景情况:
- 退行性腹 (MR) 显著影响患者的生活质量和死亡率.
- 对于退行性MR的跨导管端到端修复 (TEER) 的现实数据有限.
- 通过导管修复额头为特定患者提供了不那么侵入性的替代手术修复方法.
研究的目的:
- 评估通过导管修复退行性MR的真实结果.
- 在大量患者中评估TEER的安全性和有效性.
- 确定TEER后成功结果的预测因素.
主要方法:
- 使用来自胸部外科医生协会/美国心脏病学会跨导管治疗注册表 (2014-2022) 的数据进行了队列研究.
- 用MitraClip装置对连续接受非突发性透导管边缘至边缘门修复的患者进行了分析.
- 被定义为中度或较少残留的MR,平均位梯度<10 mm Hg. 临床结果的评估是基于残留的MR严重程度和中枢梯度.
主要成果:
- 总共包括了19088名中度至重度退行性MR患者 (中位年龄为82岁;48%为女性).
- 在88. 9%的患者中,MR成功,30天死亡率低 (2. 7%),中风 (1. 2%),再干预 (0. 97%).
- 显著降低1年死亡率 (14. 0% 与 26. 7%) 和心力衰竭再入院率 (8. 4% 与 16. 9%). 患有轻度或较少残留MR和梯度≤5mmHg的患者死亡率最低 (11. 4%).
结论:
- 通过导管修复退行性脑膜是一种安全有效的手术.
- 获得了高的MR成功率,与改善的临床结果相关.
- 获得轻度或较少的残留MR与低位梯度 (< 5 mm Hg) 与最佳生存率相关.
相关概念视频
Mitral Regurgitation III: Medical Management
20
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
20
Mitral Stenosis III: Medical Management
14
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Mitral Regurgitation I: Introduction
20
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
20
Mitral Regurgitation IV: Nursing Management
51
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
51
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
27
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
27
Mitral Valve Prolapse II: Assessment and Management
25
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
25


